Alterity Therapeutics (ATHE) Enterprise Value Growth (1y) (2010 - 2025)
Alterity Therapeutics (ATHE) Enterprise Value Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -988.88% |
| Jun 30, 2025 | -13,779.93% |
| Dec 31, 2024 | 71.11% |
| Jun 30, 2024 | 16.89% |
| Dec 31, 2023 | 55.10% |
| Jun 30, 2023 | 99.26% |
| Dec 31, 2022 | 15.16% |
| Jun 30, 2022 | -15.19% |
| Dec 31, 2021 | -5.24% |
| Jun 30, 2021 | -259.18% |
| Dec 31, 2020 | -146.08% |
| Jun 30, 2020 | 40.24% |
| Dec 31, 2019 | 4.77% |
| Jun 30, 2019 | 12.55% |
| Dec 31, 2018 | 35.08% |
| Jun 30, 2018 | 30.32% |
| Dec 31, 2017 | 21.51% |
| Jun 30, 2017 | 22.47% |
| Dec 31, 2016 | 14.63% |
| Jun 30, 2016 | 21.33% |